Documents

• The European Commission questions and answers document about the implementation of safety features for medicinal products for human use 
• EMVO “Best Practice on Alert Handling”  
• EC Study supporting the report on trends in the falsification of medicinal products and measures provided according to Directive 2011/62/EU 
• Impact assessment, companying the Commission delegated regulation (EU) 2016/161